Approximately 5,000 people in the U.S. develop amyotrophic lateral sclerosis (ALS) each year. On average, they survive for only two to five years ...

Using sequencing techniques, researchers associated 51 mutations in mitochondrial DNA with amyotrophic lateral sclerosis (ALS ...

Amyotrophic lateral sclerosis treatment industry is projected to witness a CAGR of 5.5% during the period 2024-2032. This ...

The transplantation of astrocytes — a type of brain cell as common as neurons — may provide hope of treatments or cures of ...

Report Ocean, a leading strategic consulting, and Market research firm, in its recent study, estimated Global Amayotrophic Lateral Sclerosis (ALS) Market size by value at USD 902 million in 2023.

About 7 million Americans live with chronic neurodegenerative diseases such as Parkinson’s disease, amyotrophic lateral ...

Scientists have identified a relationship between ancient viral DNA and susceptibility to neurodegenerative diseases like ...

Drugs used to slow Amyotrophic lateral sclerosis (ALS) progression may also suppress self-renewing cancerous stem cells in grade 4 glioblastoma, the most aggressive and incurable brain tumor in ...

Biogen raised its annual profit forecast on Wednesday, as new treatments and cost-cutting measures offset declining sales of ...

The mutations were mapped by a group at the Federal University of São Paulo and collaborators in an analysis of mitochondrial genomes. Thirteen increase the risk of ALS and 38 are protective.